Related content

A double-blind, randomized, multicenter, Italian study of frovatriptan versus rizatriptan for the acute treatment of migraine

By Savi Lidia   Omboni Stefano   Lisotto Carlo   Zanchin Giorgio   Ferrari Michel   Zava Dario   Pinessi Lorenzo  

The Journal of Headache and Pain, Vol. 12, Iss. 2, 2011-04 ,pp. : 219-226

Springer Publishing Company

Access to resources Recommend Favorite

Infarcts in the posterior circulation territory in migraine. The population-based MRI CAMERA study

By Kruit Mark C.  

Brain, Vol. 128, Iss. 9, 2005-09 ,pp. : 2068-2077

Oxford University Press

Access to resources Recommend Favorite

Treatment with sumatriptan 50 mg in the mild phase of migraine attacks in patients with infrequent attacks: a randomised, double-blind, placebo-controlled study

By Tfelt-Hansen P.   Bach F.   Daugaard D.   Tsiropoulos I.   Riddersholm B.  

The Journal of Headache and Pain, Vol. 7, Iss. 6, 2006-12 ,pp. : 389-394

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy of Eletriptan in Migraine Patients Reporting Unsatisfactory Response to Rizatriptan

By Goldstein J.   Tiseo P.   Denaro J.   Sikes C.  

Headache Care, Vol. 1, Iss. 4, 2004-12 ,pp. : 289-292

Informa Healthcare

Access to resources Recommend Favorite

Increased serum levels of brain-derived neurotropic factor during migraine attacks: a pilot study

By Tanure Marco   Gomez Rodrigo   Hurtado Rubens   Teixeira Antônio   Domingues Renan  

The Journal of Headache and Pain, Vol. 11, Iss. 5, 2010-10 ,pp. : 427-430

Springer Publishing Company

Access to resources Recommend Favorite